메뉴 건너뛰기




Volumn 74, Issue 4, 2015, Pages 694-702

Effect of interleukin-6 receptor blockade on surrogates of vascular risk in rheumatoid arthritis: MEASURE, a randomised, placebo-controlled study

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID A PROTEIN; APOLIPOPROTEIN A1; APOLIPOPROTEIN B; ARYLDIALKYLPHOSPHATASE; BIOLOGICAL MARKER; CORTICOSTEROID; D DIMER; FIBRINOGEN; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INTERLEUKIN 6 RECEPTOR; LIPID; LIPOPROTEIN; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN CHOLESTEROL; METHOTREXATE; OXIDIZED LOW DENSITY LIPOPROTEIN; PLACEBO; PROTEIN SPLA2 IIA; SECRETORY PHOSPHOLIPASE A2; TOCILIZUMAB; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA INHIBITOR; UNCLASSIFIED DRUG; ANTIRHEUMATIC AGENT; FIBRIN DEGRADATION PRODUCT; FIBRIN FRAGMENT D; IL6R PROTEIN, HUMAN; MONOCLONAL ANTIBODY; PHOSPHOLIPASE A2 GROUP II; SERUM AMYLOID A;

EID: 84925670384     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/annrheumdis-2013-204345     Document Type: Article
Times cited : (242)

References (31)
  • 1
    • 75749118959 scopus 로고    scopus 로고
    • EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis
    • Peters MJ, Symmons DP, McCarey D, et al. EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis. Ann Rheum Dis 2010; 69: 325-31.
    • (2010) Ann Rheum Dis , vol.69 , pp. 325-331
    • Peters, M.J.1    Symmons, D.P.2    McCarey, D.3
  • 2
    • 33846998295 scopus 로고    scopus 로고
    • HLA-DRB1 and persistent chronic inflammation contribute to cardiovascular events and cardiovascular mortality in patients with rheumatoid arthritis
    • Gonzalez-Gay MA, Gonzalez-Juanatey C, Lopez-Diaz MJ, et al. HLA-DRB1 and persistent chronic inflammation contribute to cardiovascular events and cardiovascular mortality in patients with rheumatoid arthritis. Arthritis Rheum 2007; 57: 125-32.
    • (2007) Arthritis Rheum , vol.57 , pp. 125-132
    • Gonzalez-Gay, M.A.1    Gonzalez-Juanatey, C.2    Lopez-Diaz, M.J.3
  • 3
    • 69249222895 scopus 로고    scopus 로고
    • Role for TNF in atherosclerosis? Lessons from autoimmune disease
    • McKellar GE, McCarey DW, Sattar N, et al. Role for TNF in atherosclerosis? Lessons from autoimmune disease. Nat Rev Cardiol 2009; 6: 410-17.
    • (2009) Nat Rev Cardiol , vol.6 , pp. 410-417
    • McKellar, G.E.1    McCarey, D.W.2    Sattar, N.3
  • 4
    • 0346365086 scopus 로고    scopus 로고
    • Explaining how 'high-grade' systemic inflammation accelerates vascular risk in rheumatoid arthritis
    • Sattar N, McCarey DW, Capell H, et al. Explaining how 'high-grade' systemic inflammation accelerates vascular risk in rheumatoid arthritis. Circulation 2003; 108: 2957-63.
    • (2003) Circulation , vol.108 , pp. 2957-2963
    • Sattar, N.1    McCarey, D.W.2    Capell, H.3
  • 5
    • 0035676862 scopus 로고    scopus 로고
    • Elevated levels of small, low-density lipoprotein with high affinity for arterial matrix components in patients with rheumatoid arthritis: Possible contribution of phospholipase A2 to this atherogenic profile
    • Hurt-Camejo E, Paredes S, Masana L, et al. Elevated levels of small, low-density lipoprotein with high affinity for arterial matrix components in patients with rheumatoid arthritis: Possible contribution of phospholipase A2 to this atherogenic profile. Arthritis Rheum 2001; 44: 2761-67.
    • (2001) Arthritis Rheum , vol.44 , pp. 2761-2767
    • Hurt-Camejo, E.1    Paredes, S.2    Masana, L.3
  • 6
    • 77955478708 scopus 로고    scopus 로고
    • Lipoprotein subclasses determined by nuclear magnetic resonance spectroscopy and coronary atherosclerosis in patients with rheumatoid arthritis
    • Chung CP, Oeser A, Raggi P, et al. Lipoprotein subclasses determined by nuclear magnetic resonance spectroscopy and coronary atherosclerosis in patients with rheumatoid arthritis. J Rheumatol 2010; 37: 1633-8.
    • (2010) J Rheumatol , vol.37 , pp. 1633-1638
    • Chung, C.P.1    Oeser, A.2    Raggi, P.3
  • 7
    • 64949111191 scopus 로고    scopus 로고
    • Interpreting lipid levels in the context of high-grade inflammatory states with a focus on rheumatoid arthritis: A challenge to conventional cardiovascular risk actions
    • Choy E, Sattar N. Interpreting lipid levels in the context of high-grade inflammatory states with a focus on rheumatoid arthritis: A challenge to conventional cardiovascular risk actions. Ann Rheum Dis 2009; 68: 460-9.
    • (2009) Ann Rheum Dis , vol.68 , pp. 460-469
    • Choy, E.1    Sattar, N.2
  • 8
    • 33746095378 scopus 로고    scopus 로고
    • Small dense low-density lipoprotein and its role as an independent predictor of cardiovascular disease
    • Packard CJ. Small dense low-density lipoprotein and its role as an independent predictor of cardiovascular disease. Curr Opin Lipidol 2006; 17: 412-17.
    • (2006) Curr Opin Lipidol , vol.17 , pp. 412-417
    • Packard, C.J.1
  • 9
    • 3042606551 scopus 로고    scopus 로고
    • Effects of infection and inflammation on lipid and lipoprotein metabolism: Mechanisms and consequences to the host
    • Khovidhunkit W, Kim MS, Memon RA, et al. Effects of infection and inflammation on lipid and lipoprotein metabolism: Mechanisms and consequences to the host. J Lipid Res 2004; 45: 1169-96.
    • (2004) J Lipid Res , vol.45 , pp. 1169-1196
    • Khovidhunkit, W.1    Kim, M.S.2    Memon, R.A.3
  • 10
    • 73549097512 scopus 로고    scopus 로고
    • Genetic variants associated with Lp(a) lipoprotein level and coronary disease
    • Clarke R, Peden JF, Hopewell JC, et al. Genetic variants associated with Lp(a) lipoprotein level and coronary disease. N Engl J Med 2009; 361: 2518-28.
    • (2009) N Engl J Med , vol.361 , pp. 2518-2528
    • Clarke, R.1    Peden, J.F.2    Hopewell, J.C.3
  • 11
    • 70350033694 scopus 로고    scopus 로고
    • Circulating inflammatory and hemostatic biomarkers are associated with risk of myocardial infarction and coronary death, but not angina pectoris, in older men
    • Wannamethee SG, Whincup PH, Shaper AG, et al. Circulating inflammatory and hemostatic biomarkers are associated with risk of myocardial infarction and coronary death, but not angina pectoris, in older men. J Thromb Haemost 2009; 7: 1605-11.
    • (2009) J Thromb Haemost , vol.7 , pp. 1605-1611
    • Wannamethee, S.G.1    Whincup, P.H.2    Shaper, A.G.3
  • 12
    • 77953980528 scopus 로고    scopus 로고
    • IL-6: From its discovery to clinical applications
    • Kishimoto T. IL-6: From its discovery to clinical applications. Int Immunol 2010; 22: 347-52.
    • (2010) Int Immunol , vol.22 , pp. 347-352
    • Kishimoto, T.1
  • 13
    • 67650217953 scopus 로고    scopus 로고
    • Are markers of inflammation more strongly associated with risk for fatal than for nonfatal vascular events?
    • Sattar N, Murray HM, Welsh P, et al. Are markers of inflammation more strongly associated with risk for fatal than for nonfatal vascular events?. PLoS Med 2009; 6: E1000099.
    • (2009) PLoS Med , vol.6 , pp. e1000099
    • Sattar, N.1    Murray, H.M.2    Welsh, P.3
  • 14
    • 43249118045 scopus 로고    scopus 로고
    • Long-Term interleukin-6 levels and subsequent risk of coronary heart disease: Two new prospective studies and a systematic review
    • Danesh J, Kaptoge S, Mann AG, et al. Long-Term interleukin-6 levels and subsequent risk of coronary heart disease: Two new prospective studies and a systematic review. PLoS Med 2008; 5: E78.
    • (2008) PLoS Med , vol.5 , pp. e78
    • Danesh, J.1    Kaptoge, S.2    Mann, A.G.3
  • 15
    • 79956319051 scopus 로고    scopus 로고
    • Progress and challenges in translating the biology of atherosclerosis
    • Libby P, Ridker PM, Hansson GK. Progress and challenges in translating the biology of atherosclerosis. Nature 2011; 473: 317-25.
    • (2011) Nature , vol.473 , pp. 317-325
    • Libby, P.1    Ridker, P.M.2    Hansson, G.K.3
  • 16
    • 84859215358 scopus 로고    scopus 로고
    • The interleukin-6 receptor as a target for prevention of coronary heart disease: A Mendelian randomisation analysis
    • Interleukin 6 Receptor Mendelian Randomisation Analysis (IL6R MR) ConsortiumHingorani AD, Casas JP. The interleukin-6 receptor as a target for prevention of coronary heart disease: A Mendelian randomisation analysis. Lancet 2012; 379: 1214-24.
    • (2012) Lancet , vol.379 , pp. 1214-1224
    • Hingorani, A.D.1    Casas, J.P.2
  • 17
    • 84859210770 scopus 로고    scopus 로고
    • Interleukin-6 receptor pathways in coronary heart disease: A collaborative meta-Analysis of 82 studies
    • IL6R Genetics Consortium Emerging Risk Factors CollaborationSarwar N, Butterworth AS, et al. Interleukin-6 receptor pathways in coronary heart disease: A collaborative meta-Analysis of 82 studies. Lancet 2012; 379: 1205-13.
    • (2012) Lancet , vol.379 , pp. 1205-1213
    • Sarwar, N.1    Butterworth, A.S.2
  • 18
    • 33748644710 scopus 로고    scopus 로고
    • Rheumatoid arthritis is associated with increased aortic pulse-wave velocity, which is reduced by anti-Tumor necrosis factor-Alpha therapy
    • Mäki-Petäjä KM, Hall FC, Booth AD, et al. Rheumatoid arthritis is associated with increased aortic pulse-wave velocity, which is reduced by anti-Tumor necrosis factor-Alpha therapy. Circulation 2006; 114: 1185-92.
    • (2006) Circulation , vol.114 , pp. 1185-1192
    • Mäki-Petäjä, K.M.1    Hall, F.C.2    Booth, A.D.3
  • 19
    • 33750318148 scopus 로고    scopus 로고
    • Expert consensus document on arterial stiffness: Methodological issues and clinical applications
    • Laurent S, Cockcroft J, Van Bortel L, et al. Expert consensus document on arterial stiffness: Methodological issues and clinical applications. Eur Heart J 2006; 27: 2588-605.
    • (2006) Eur Heart J , vol.27 , pp. 2588-2605
    • Laurent, S.1    Cockcroft, J.2    Van Bortel, L.3
  • 20
    • 79951739491 scopus 로고    scopus 로고
    • Interleukin-6 inhibition for treatment of rheumatoid arthritis: A review of tocilizumab therapy
    • Patel AM, Moreland LW. Interleukin-6 inhibition for treatment of rheumatoid arthritis: A review of tocilizumab therapy. Drug Design Dev Ther 2010; 4: 263-78.
    • (2010) Drug Design Dev Ther , vol.4 , pp. 263-278
    • Patel, A.M.1    Moreland, L.W.2
  • 21
    • 80053483450 scopus 로고    scopus 로고
    • Tocilizumab monotherapy reduces arterial stiffness as effectively as etanercept or adalimumab monotherapy in rheumatoid arthritis: An open-label randomized controlled trial
    • Kume K, Amano K, Yamada S, et al. Tocilizumab monotherapy reduces arterial stiffness as effectively as etanercept or adalimumab monotherapy in rheumatoid arthritis: An open-label randomized controlled trial. J Rheumatol 2011; 38: 2169-71.
    • (2011) J Rheumatol , vol.38 , pp. 2169-2171
    • Kume, K.1    Amano, K.2    Yamada, S.3
  • 22
    • 66049109843 scopus 로고    scopus 로고
    • Improvement of lipid profile is accompanied by atheroprotective alterations in high-density lipoprotein composition upon tumor necrosis factor blockade: A prospective cohort study in ankylosing spondylitis
    • van Eijk IC, de Vries MK, Levels JH, et al. Improvement of lipid profile is accompanied by atheroprotective alterations in high-density lipoprotein composition upon tumor necrosis factor blockade: A prospective cohort study in ankylosing spondylitis. Arthritis Rheum 2009; 60: 1324-30.
    • (2009) Arthritis Rheum , vol.60 , pp. 1324-1330
    • Van Eijk, I.C.1    De Vries, M.K.2    Levels, J.H.3
  • 23
    • 0141885327 scopus 로고    scopus 로고
    • Small, dense HDL particles exert potent protection of atherogenic LDL against oxidative stress
    • Kontush A, Chantepie S, Chapman MJ. Small, dense HDL particles exert potent protection of atherogenic LDL against oxidative stress. Arterioscler Thromb Vasc Biol 2003; 23: 1881-8.
    • (2003) Arterioscler Thromb Vasc Biol , vol.23 , pp. 1881-1888
    • Kontush, A.1    Chantepie, S.2    Chapman, M.J.3
  • 24
    • 77950335656 scopus 로고    scopus 로고
    • Overproduced interleukin 6 decreases blood lipid levels via upregulation of very-low-density lipoprotein receptor
    • Hashizume M, Yoshida H, Koike N, et al. Overproduced interleukin 6 decreases blood lipid levels via upregulation of very-low-density lipoprotein receptor. Ann Rheum Dis 2010; 69: 741-6.
    • (2010) Ann Rheum Dis , vol.69 , pp. 741-746
    • Hashizume, M.1    Yoshida, H.2    Koike, N.3
  • 25
    • 0033927969 scopus 로고    scopus 로고
    • Interleukin-6 stimulates LDL receptor gene expression via activation of sterol-responsive and Sp1 binding elements
    • Gierens H, Nauck M, Roth M, et al. Interleukin-6 stimulates LDL receptor gene expression via activation of sterol-responsive and Sp1 binding elements. Arterioscler Thromb Vasc Biol 2000; 20: 1777-83.
    • (2000) Arterioscler Thromb Vasc Biol , vol.20 , pp. 1777-1783
    • Gierens, H.1    Nauck, M.2    Roth, M.3
  • 26
    • 84860331375 scopus 로고    scopus 로고
    • Atherogenic effects of TNF-A and IL-6 via up-regulation of scavenger receptors
    • Hashizume M, Mihara M. Atherogenic effects of TNF-A and IL-6 via up-regulation of scavenger receptors. Cytokine 2012; 58: 424-30.
    • (2012) Cytokine , vol.58 , pp. 424-430
    • Hashizume, M.1    Mihara, M.2
  • 27
    • 0036511148 scopus 로고    scopus 로고
    • Changes in the concentration and composition of plasma lipoproteins during the acute phase response
    • Carpentier YA, Scruel O. Changes in the concentration and composition of plasma lipoproteins during the acute phase response. Curr Opin Clin Nutr Metab Care 2002; 5: 153-8.
    • (2002) Curr Opin Clin Nutr Metab Care , vol.5 , pp. 153-158
    • Carpentier, Y.A.1    Scruel, O.2
  • 28
    • 0032974070 scopus 로고    scopus 로고
    • Fibrinolytic activation markers predict myocardial infarction in the elderly: The Cardiovascular Health Study
    • Cushman M, Lemaitre RN, Kuller LH, et al. Fibrinolytic activation markers predict myocardial infarction in the elderly: The Cardiovascular Health Study. Arterioscler Thromb Vasc Biol 1999; 19: 493-8.
    • (1999) Arterioscler Thromb Vasc Biol , vol.19 , pp. 493-498
    • Cushman, M.1    Lemaitre, R.N.2    Kuller, L.H.3
  • 29
    • 0035873876 scopus 로고    scopus 로고
    • Fibrin D-dimer and coronary heart disease: Prospective study and meta-Analysis
    • Danesh J, Whincup P, Walker M, et al. Fibrin D-dimer and coronary heart disease: Prospective study and meta-Analysis. Circulation 2001; 103: 2323-7.
    • (2001) Circulation , vol.103 , pp. 2323-2327
    • Danesh, J.1    Whincup, P.2    Walker, M.3
  • 30
    • 67651210632 scopus 로고    scopus 로고
    • Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality
    • Emerging Risk Factors CollaborationErqou S, Kaptoge S, et al. Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality. JAMA 2009; 302: 412-23.
    • (2009) JAMA , vol.302 , pp. 412-423
    • Erqou, S.1    Kaptoge, S.2
  • 31
    • 33947098982 scopus 로고    scopus 로고
    • Effects of tumor necrosis factor blockade on cardiovascular risk factors in psoriatic arthritis: A double-blind, placebo-controlled study
    • Sattar N, Crompton P, Cherry L, et al. Effects of tumor necrosis factor blockade on cardiovascular risk factors in psoriatic arthritis: A double-blind, placebo-controlled study. Arthritis Rheum 2007; 56: 831-9.
    • (2007) Arthritis Rheum , vol.56 , pp. 831-839
    • Sattar, N.1    Crompton, P.2    Cherry, L.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.